Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GCAR1 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on GCAR1, a putative chimeric antigen receptor (CAR) T-cell therapy targeting GPNMB (Mar 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GCAR1 | GCAR 1|GCAR-1 | Limited information is currently available on GCAR1, a putative chimeric antigen receptor (CAR) T-cell therapy targeting GPNMB (Mar 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07104682 | Phase I | GCAR1 | A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB) | Not yet recruiting | CAN | 0 |